The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Mitochondrial DNA released by senescent tumor cells enhances PMN-MDSC-driven immunosuppression through the cGAS-STING pathway
Open accessAbstract
Mitochondrial dysfunction is a hallmark of cellular senescence. Here, we investigated whether senescent cells release mitochondrial (mt)DNA into the extracellular space and its impact on innate immunity. We found that both primary senescent cells and tumor cells undergoing therapy-induced senescence actively released mtDNA into the extracellular environment. mtDNA released by senescent cells was packaged within extracellular vesicles and selectively transferred to polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) in the tumor microenvironment. Upon uptake, extracellular mtDNA enhanced the immunosuppressive activity of PMN-MDSCs via cGAS-STING-NF-κB signaling, thereby promoting tumor progression. While STING activation directly induced NF-κB signaling, it also activated PKR-like endoplasmic reticulum kinase (PERK), which further amplified NF-κB activity, in PMN-MDSCs. mtDNA release from senescent cells was mediated by voltage-dependent anion channels (VDACs), and pharmacological inhibition of VDAC reduced extracellular mtDNA levels, reversed PMN-MDSC-driven immunosuppression, and enhanced chemotherapy efficacy in prostate cancer mouse models. These findings suggest that targeting mtDNA release could reprogram the immunosuppressive tumor microenvironment, improving therapeutic outcomes for chemotherapy-treated patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It can recognize mtDNA released during liver injury, leading to its activation and the triggering of inflammation with the production of type I interferons (IFNs) and proinflammatory cytokines, which exacerbates liver inflammation and hepatocyte damage (20–22).”
From Matrix mechanical remodeled carrier-free nanosystem for programmable closed-loop reversal of liver fibrosis via STING alkylation (2025) · cites this paper as [20]
Citations
Cites
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Bronte, V., Brandau, S., Chen, S.-H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12150 · Cited by 2,751
Hallmarks of Cellular Senescence
Hernandez-Segura, A., Nehme, J., & Demaria, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.001 · Cited by 2,605
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Mitochondrial DNA stress primes the antiviral innate immune response
West, A. P., Khoury-Hanold, W., Staron, M., Tal, M. C., Pineda, C. M., Lang, S. M., Bestwick, M., Duguay, B. A., Raimundo, N., MacDuff, D. A., et al. (2015) · Nature · doi:10.1038/nature14156 · Cited by 1,975
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Veglia, F., Sanseviero, E., & Gabrilovich, D. I. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00490-y · Cited by 1,940
Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
Gong, T., Liu, L., Jiang, W., & Zhou, R. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0215-7 · Cited by 1,672
Self-citation
Cited by
Sorted by citations
Bai, X., Guo, Y.-R., Zhao, Z., Li, X., Dai, D.-Q., Zhang, J., Li, Y.-S., & Zhang, C. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217772 · Cited by 140
Self-citationColucci, M., Sarill, M., Maddalena, M., Valdata, A., Troiani, M., Massarotti, M., Bolis, M., Bressan, S., Kohl, A., Robesti, D., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.05.015 · Cited by 143
Self-citationLi, H., Cai, R., Zhou, Y., Jiang, Y., & Tan, S. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03563-8 · Cited by 72
Cellular senescence in cancer: from mechanism paradoxes to precision therapeutics
Feng, T., Xie, F., Lee, L. M.-Y., Lin, Z., Tu, Y., Lyu, Y., Yu, P., Wu, J., Chen, B., Zhang, G., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02419-2 · Cited by 70
The cGAS-STING pathway: a dual regulator of immune response in cancer and therapeutic implications
Huang, Z., Zhu, J., Zhou, Y. L., & Shi, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06843-2 · Cited by 60
Mitochondrial RNA cytosolic leakage drives the SASP
Victorelli, S. G., Eppard, M., Martini, H., Woo, S., Everts, S. P. A., Lee, G., Pirius, N., Han, N., Liang, E. Y., Franco, A. C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66159-z · Cited by 39
Breaking barriers: The cGAS‐STING pathway as a novel frontier in cancer immunotherapy
Yan, Y., Tan, X., Song, B., Yi, M., Chu, Q., & Wu, K. (2025) · 癌症:英文版 · doi:10.1002/cac2.70067 · Cited by 35
Context-dependent impact of type I interferon signaling in cancer
Ruiz-Iglesias, A., Guilbaud, E., Galluzzi, L., & Mañes, S. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02495-4 · Cited by 25
Wang, C., Zhang, W., Shu, Y., Song, L., Wan, Y., Zhang, H., Bo, L., & Guo, Y. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108194 · Cited by 22
DAMP signaling networks: from receptors to diverse pathophysiological functions
Chen, R., Zou, J., Zhong, X. Y., Liu, J., Kang, R., & Tang, D. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.07.047 · Cited by 26
Yin, L., Zhou, S., Zhang, H., Yao, C., Al-Qadhi, Z. T. A., Shang, Y., Wu, S., & Jin, T. (2025) · Antibody Therapeutics · doi:10.1093/abt/tbaf017 · Cited by 19
Cytosolic DNA crosstalk in senescence: a new axis of inflammatory signaling?
Dou, Z., Kreiling, J. A., Heynen‐Genel, S., Jurk, D., Neretti, N., Adams, P. D., Sedivy, J. M., & Passos, J. F. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00531-z · Cited by 17
Zhao, L., Liang, K., Cheng, W., Zhou, X., Yang, L., Mao, X., Qi, W., Jin, H., Zhang, W., Pan, H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63194-8 · Cited by 16
The cGAS-STING pathway: Mechanism and medical implications
Hooftman, A., Keller, A., & Ablasser, A. (2026) · Cell · doi:10.1016/j.cell.2026.06.001 · Cited by 24
The dual role of VDAC in cancer: Molecular mechanisms and advances in targeted therapy
Huang, H., Chen, M., Feng, S., Lin, Z., & Liu, Y. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118530 · Cited by 18
Morciano, G., Pellielo, G., Agyapong, E. D., Pellegrino, C., Patergnani, S., Franceschini, D., Koutsikos, K., Rigon, L., Pinton, P., & Rimessi, A. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07783-1 · Cited by 17
Precision targeting of STING: Challenges, innovations, and clinical outlook for cancer therapy
Shi, J., Zhang, Y., Zhao, N., Seki, E., Ma, L., Kocic, G. M., Li, X., Terzić, J., & Zheng, T. (2025) · The Innovation · doi:10.1016/j.xinn.2025.101074 · Cited by 16
Mittal, R., Goldmann, R., Mittal, M., Chaudhary, N., Ravindra, V., & Hirani, K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1744422 · Cited by 13
Shi, H., Xiao, M., Li, Y., Liu, X., Na, J., Liang, C., Hua, J., Meng, Q., Wei, M., Wang, W., et al. (2025) · Theranostics · doi:10.7150/thno.112633 · Cited by 12
Self-citationThe roles of the mtDNA-cGAS-STING axis in tumor immunity: from immune activation to immune evasion
Huang, N., Liu, Z., Lei, H., & Liu, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1739559 · Cited by 11
mtDNA transfer from senescent cancer cells to MDSCs promotes immunosuppression
Cañadas, I., Murayama, T., & Galluzzi, L. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.06.010 · Cited by 11
The interplay between DNA damage response and mitochondrial dysfunction in radiotherapy
Yang, S., Li, Y., Zhang, J., Shen, A., Hu, B., & Yan, J. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1642100 · Cited by 16
Self-citationImmunosenescence: Molecular Mechanisms, Diseases, and Therapeutic Innovations
Gong, N., Pan, X., Deng, Y., Che, J., Bao, J., Wang, M., Xu, C., Liu, X., & Shi, Y. (2025) · MedComm · doi:10.1002/mco2.70515 · Cited by 14
The pre-metastatic niche: mechanisms, heterogeneity, and therapeutic opportunities
Zhang, X.-R., Wei, B., Jiang, B.-H., & Ren, W. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02645-2 · Cited by 10
Lv, J., Xu, W., Jiang, P., Yu, W., Xue, H., Hu, N., Cao, Y., Zhang, H., Yin, C., & Gao, R. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08585-5 · Cited by 10
Xu, S., Yang, N., Du, F., Zhang, Z., Zhang, Y., Zhang, Y., Liang, J., Zhao, Y., Zhang, J., Zhang, Z., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03795-z · Cited by 8
Long, D., Mao, C., Zhu, Y., & Xu, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1594120 · Cited by 7
Chen, Z., Feng, Z., Wang, S., & Zhang, J. (2025) · Advanced Science · doi:10.1002/advs.202515006 · Cited by 7
Han, H., Yu, D., Liu, Y., Jia, H., & Liu, W. (2025) · Science Advances · doi:10.1126/sciadv.adz4126 · Cited by 7
Mitochondrial DNA as a driver of inflammation via the cGAS-STING pathway
Wen, X., Yang, F., Zhang, L., & Huang, D. (2026) · Inflammation Research · doi:10.1007/s00011-026-02231-8 · Cited by 6
Mitochondrial quality control in health and disease: mechanisms and therapeutic targets
Creus, A., Mohapatra, S., Ortega, L., & Sebastián, D. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02813-2 · Cited by 7
Wei, Y., Cai, S., Ji, Y., Wang, J., Shang, T., Dai, B., & Sun, H. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118317 · Cited by 6
Li, S., Lu, E., Mi, L., Li, C., Guan, H., Cao, T., & Zhang, Q. (2025) · Discover Oncology · doi:10.1007/s12672-025-03926-w · Cited by 4
Xie, Z., Li, S., Yang, J., Zhang, Z., Li, S., Lang, C., Yang, M., Wang, B., Yu, X., Li, Z., et al. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218326 · Cited by 5
Harnessing myeloid cell plasticity for cancer therapy
Sanseviero, E., Barry, S. T., & Gabrilovich, D. I. (2026) · Nature Cancer · doi:10.1038/s43018-026-01159-6 · Cited by 5
The cGAS–STING pathway in cancer immunotherapy: prognostic value and therapeutic potential
Alabi, F. A., Imodoye, S. O., Adedokun, K. A., Eltokhy, M. A., Curcic, M., Okoyeocha, E., Thapa, I., Tiwari, S., Ogundele, A. V., Ayo, T. E., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1760947 · Cited by 5
The cGAS-STING pathway in age-related ocular diseases: Mechanisms and therapeutic opportunities
Shang, Z., Qin, D., Liu, X., Li, H., Liu, C., Zhang, R., Sun, T., Pan, Z., Feng, W., & You, X.-G. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112069 · Cited by 3
Ma, N., Xu, Y., Zhang, D., Zhang, H., Luo, W., Cao, Y., & Wong, V. K. W. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103961 · Cited by 4
Advances in the application of PD-1/PD-L1 immunotherapy for prostate cancer: a review
Hu, G., Li, Z., Chen, Y., Liao, H., & Zhou, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1664587 · Cited by 3
Wang, Y., Lu, X., Tan, J. M., He, J., Yin, H., Chen, P., Wu, H., Luo, Y., & Li, M. (2025) · Life Conflux · doi:10.71321/dr57c347 · Cited by 3
Cell‐Free DNA‐Based Theranostics for Inflammatory Disorders
Li, J., Wang, Y., Fan, X., Xu, M., Li, J., Tan, W., Zhang, J., & Li, H. (2026) · Advanced Science · doi:10.1002/advs.202520383 · Cited by 4
Zhou, J., Li, H., Wen, Y., He, L., He, Y., & Meng, H. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04685-y · Cited by 3
Wu, C., Fu, Q., Liu, J., Fu, J., Zhang, B., Zhou, J., Xu, J., Zhang, Y., Zhu, T., Yang, L., et al. (2026) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2026.101049 · Cited by 3
Kang, L., Feng, C., Tang, Z., Gu, W., Wang, Y., Pei, A., & Piao, M. (2026) · iScience · doi:10.1016/j.isci.2026.115275 · Cited by 3
Arumugam, P., Heim, C. E., Fallet, R. W., Shinde, D., Thomas, V. C., Argüello, R. J., & Kielian, T. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117057 · Cited by 3
Yu, Q., Guo, K., Yang, Y., Liu, H., Han, Y., Yu, X., Wang, J., Zhao, Y., Su, X., Zhu, K., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04251-2 · Cited by 3
Choi, M., Lee, D., Yang, W.-H., & Cha, J. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08688-z · Cited by 4
Danger or Salvation? The Role of DAMPs in Cancer Therapy
Vedunova, A. A., Guryev, E. L., Gudkov, S. V., Mishchenko, T. A., & Vedunova, M. V. (2026) · Cancers · doi:10.3390/cancers18091442 · Cited by 3
The Role of Mitochondrial Genome Stability and Metabolic Plasticity in Thyroid Cancer
Ren, L., Liu, W., Zheng, J., Wu, Q. Y., & Ai, Z. (2025) · Biomedicines · doi:10.3390/biomedicines13112599 · Cited by 2
Mitochondrial involvement in PC: improving therapeutic strategies
Zhang, J., & Lou, C. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1710923 · Cited by 2
Wei, Q., Zhao, K., Wu, Y., Wu, W., & Hao, N. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70531 · Cited by 2
Wu, Z., Bao, S., Chen, Q., Xiao, L., Guan, G., Song, R., Chen, Q., & Chen, X. (2025) · International Dental Journal · doi:10.1016/j.identj.2025.109303 · Cited by 2
Prokaryotic organelle mitochondria drive tumorigenesis: “the original sin”
Wang, C., Luo, M., Zhou, J., Zhang, Q., Xiawei, J., He, J., Wang, L., Huang, Y., Xu, X., & 王方岩 (2026) · Frontiers in Oncology · doi:10.3389/fonc.2025.1632702 · Cited by 3
Devale, T., Katuri, L., Mishra, G., Acharya, A., Manivannan, P., Hibbard, B. R., & Malathi, K. (2026) · Cells · doi:10.3390/cells15020139 · Cited by 2
Li, Y., Zhang, Y., Nie, R., Yan, C., Tao, Y., Liu, X., Ning, H., Yuan, K., Liu, Z., Liu, Z., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c19551 · Cited by 2
Self-citationcGAS–STING signaling pathway in urogenital oncology: Regulation, resistance, and routes to response
Gong, C., Li, S., Huang, Y., Luo, E., Tan, Z., Li, H., Kong, Y., & Ding, M. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105222 · Cited by 2
cGAS-STING signaling in pollution-induced toxicity: mechanism and relieving medication
Yan, M., Li, S., Wei, Y., Wu, J., Zhou, X., Yang, K., & Liang, Y. A. N. G. (2026) · APOPTOSIS · doi:10.1007/s10495-026-02301-6 · Cited by 2
Challenges and advances in drug resistance and tolerance in cancer
Bivona, T. G., Yanai, I., Calabrò, F., Mechta‐Grigoriou, F., Corleone, G., Martile, M. D., Tocci, A., Tocci, P., Vaccarella, S., Ferriero, M., et al. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-026-03665-y · Cited by 2
Self-citationEpigenetic dynamics of cellular senescence: From mechanistic insights to precision senotherapy
Hu, X., Lai, W., Liu, M., & Wang, B. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004042 · Cited by 2
Inside Out: How Cellular Localisation Shapes cGAS Functions in Health and Disease
Wu, J., Zhou, Y., Zeng, B., Wang, Y., & Wang, C. (2026) · Immunology · doi:10.1111/imm.70133 · Cited by 2
Cuproptosis in spinal cord injury: emerging mechanisms and immunological relevance
Li, L.-H., Zhang, J.-Q., Ying, X.-H., Huang, Y., Xu, C.-C., Wang, X., He, K.-L., & Ma, R. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2641867 · Cited by 2
Luo, Q., Li, F., Yang, L., Pan, H., Zhu, W., Hu, P., Tao, C., Yin, M., Zhang, S., Liao, Q., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71423 · Cited by 4
Xu, P., Shen, N., 邱添, Zhou, M., Li, R., Tao, C., Zhu, Y., & Hu, W. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03847-7 · Cited by 2
Wang, B., Zeng, H., Zhan, H., Xu, Y., Hu, Z., Pang, J., Zhang, Z., Ma, Y., & Wu, W. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08314-8 · Cited by 2
Multi-region proteomic mapping identifies FTL1 and SERPINA3K as protective factors in cardiac aging
Huang, J., Sun, X., Liu, H., Li, K. E. X. I. N., Liu, X., Bai, Y., Dong, Z., Wu, X., Liu, X., Jia, L., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08882-z · Cited by 2
Park, W. H. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109086 · Cited by 2
The cGAS/STING pathway in cancer: translating innate DNA sensing into therapeutic potential
Wang, Y., Angulo-Lozano, J. C., Wang, Y., & Deng, L. (2026) · Journal of Clinical Investigation · doi:10.1172/jci204552 · Cited by 2
Immune surveillance and immune evasion of senescent cells
Garcia-Baucells, P., Serrano, M., & Amor, C. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01335-w · Cited by 4
The mtDNA-ZBP1 axis in alzheimer's disease: Mechanisms, pathogenesis, and therapeutic implications
Chen, Y., Liu, Y., Hu, H., & Li, S. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115853 · Cited by 1
Dendritic cell-derived biomimetic vesicles as cancer vaccine platforms for melanoma immunotherapy
Liu, J., Lu, J., Miao, F., Wu, L., Ding, L., Ma, T., Wang, R., Han, Y., Cui, Z., Chen, Z., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114405 · Cited by 1
Li, T., Huang, M., Cai, J., Li, X., Xing, Y., He, R., Wan, Z., Gan, Y., Li, Z., Weng, J., et al. (2026) · Advanced Science · doi:10.1002/advs.202518536 · Cited by 1
Xing, B., Liu, J., Xie, Y., Liu, P., Zhang, L., Tian, W., Yu, W., Wang, H., Wang, J., Sun, Z., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-2611 · Cited by 1
Targeting Myeloid-Derived Suppressor Cells: A Promising Strategy for Cancer Treatment
Wang, Z., Li, M., Hua, D., Hu, X., & Wang, Y. (2026) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-025-00485-y · Cited by 1
Wang, Q., Sun, X., Han, X., Zhang, X., Wang, W., Wang, H., Ren, H., & Gu, L. (2026) · MedComm – Oncology · doi:10.1002/mog2.70054 · Cited by 1
Myeloid-derived suppressor cells promote therapy-induced resistance in prostate cancer
Liu, A., Song, P., Liu, Z., Colucci, M., Lai, P., Yang, L., Yan, X., Qiu, H., & Dong, Q. (2026) · International Journal of Surgery · doi:10.1097/js9.0000000000004227 · Cited by 1
Self-citationTargeting the cGAS-STING pathway in ophthalmology: from innate immunity to therapeutic innovation
Yan, D., Ouyang, W., Li, K., & Sun, X. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.110978 · Cited by 1
Zhu, D., Huang, W., Wang, Y., Yang, Y., Su, F., Lu, C., Lin, Z., Zhou, E., Chen, Z., Liu, R., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.175330 · Cited by 1
Zhang, Z., Tong, J., Cao, X., Xu, W., Qi, Z., Kuang, X., Huang, Y., He, Y., Zeng, C., Hu, M., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.175311 · Cited by 3
Yang, X., Wu, S. Q., Dou, Z., Dong, Y., & Dai, J. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18040425 · Cited by 1
Sun, J., Yang, F., Li, Y., Li, S., & Song, J. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218527 · Cited by 2
Self-citationVDAC2 deficiency: a new target for cancer immunotherapy and regulation of inflammatory responses
Fu, Y., Gao, F., & Yu, Y. (2026) · Medicine Plus · doi:10.1016/j.medp.2026.100139 · Cited by 1
Mitochondrial Stress Orchestrates Tumor Immune Evasion and Immunotherapy Resistance
Bılır, A., Yıldırım, B., & Karalök, M. H. (2026) · Cells · doi:10.3390/cells15100890 · Cited by 1
Bridging aging and colorectal cancer: synergistic roles of inflammaging and immunosenescence
Zaongo, S. D., Yang, Q., Han, M., Xi, T., Luo, Z., Wang, X., Yang, J., & Ouyang, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1792954 · Cited by 2
Zhong, S., Chen, W., Liu, F., Zhou, S., Yu, B., Wang, Y., Zhou, X., Wang, X., Liu, D., Zhang, Z., et al. (2026) · Advanced Science · doi:10.1002/advs.76321 · Cited by 1
Self-citationYao, M., Liu, A., Xing, L., Song, J., Yang, Y., Yue, X., & Li, H. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103260 · Cited by 1
Xu, Z., Guo, J., Liu, Z., Yu, J., Yuan, R., Min, Y., Wei, Z., & Peng, X. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103270 · Cited by 1
Qin, D., Lei, Y., Le, M., Cheng, M., Zhao, Y., Xia, L., Li, X., & Dong, X. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04848-x · Cited by 1
Feng, S., Hu, Y., Li, S., 常玉巧, Li, Z., Liu, Y., & Xu, K. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105530 · Cited by 2
Chen, X., Ding, J., Liu-qing, M. E. N. G., Li, S., Chen, Y., Wei, X., Hu, W., Wang, K., Yao, F., Zhao, Y.-J., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117316 · Cited by 1
STING’s suppressive turn in PMN-MDSCs
Liang, D., & Zheng, S. G. (2025) · Aging Research · doi:10.26599/agr.2025.9340052
Recharging cellular immunotherapy – targeting immunometabolic aging
Rallis, K. S., Pommier, A., Singh, A. K., & Cancelas, J. A. (2025) · Immunotherapy · doi:10.1080/1750743x.2025.2607468
Shen, Q., Pan, X., Li, J., Li, Y., Lin, J., Liu, F., Jiang, X., Zhang, C., & Pang, B. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-025-07659-w
Self-citationGanciclovir for refractory allergic rhinitis: a case series and literature review
Hu, Q., Hao, Y., Gao, P., Long, Z., Huo, B., Cheng, X., Xie, T., Li, L., Zhou, T., Zhou, L., et al. (2026) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-025-09977-7
Self-citationTang, H., & Liu, S. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168171
The human and murine immune systems: regulated by dichotomous molecules
Silva, R. C. M. C. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116329
Liang, X., Li, Z., Zeng, G., Qin, J., Yuan, L., Zhou, Y., Tao, N., Deng, L., Wang, D., & Chen, J. (2026) · Advanced Composites and Hybrid Materials · doi:10.1007/s42114-026-01682-1
Self-citationMultifacet Roles of Cellular Senescence in Cancer: Mechanisms and Therapeutic Implications
Mao, H., Liu, W., Su, Y., Ma, Y., Zhao, X., & Lu, Y. (2026) · MedComm – Oncology · doi:10.1002/mog2.70060 · Cited by 1
Zhou, J., Qiu, T., Hu, Z., Xiao, D., & Liu, Z. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116424
Mitochondria and tumor microenvironment
Taghizadeh‐Hesary, F., & Bitarafan, F. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40535-8.00017-x
RNA Methylation and T Cells in Tumor Immunity: Functions, Therapeutic Strategies, and Prospections
Shang, S., & Ma, L. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1015037
Metadata
- Authors
- Lai, P., Liu, L., Bancaro, N., Troiani, M., Calì, B., Li, Y., Chen, J., Singh, P. K., Arzola, R. A., Attanasio, G., Pernigoni, N., Pasquini, E., Mosole, S., Rinaldi, A., Sgrignani, J., Qiu, S., Song, P., Li, Y., Desbats, M. A., Ángel, A. R., Mestre, R. P., Cavalli, A., Barile, L., de Bono, J., & Alimonti, A.
- Affiliations
- Institute of Oncology Research (CH)
- Institute for Research in Biomedicine (CH)
- West China Hospital of Sichuan University (CN)
- Ente Ospedaliero Cantonale (CH)
- Istituto Cardiocentro Ticino (CH)
- University of Padua (IT)
- Corresponding author
- Alimonti, Andrea
- ORCID
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2025-04
- Volume
- 58
- Issue
- 4
- Pages
- 811-825.e7
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W4409254393
- Cited by
- 174
- References
- 65
- Citations by year
- 2026: 139 · 2025: 35
- FWCI
- 64.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Immunity (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Repository for Publications and Research Data (ETH Zurich) (publishedVersion, cc-by-nc)
- IRIS (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by-nc-nd)
- ETH Zürich Research Collection
- Funders
- European Research Council (CoG 683136)
- Cancer Research Foundation Switzerland (KFS-5262-02-2021, KFS-4267-08-2017, RWP-4813-06-2019)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (201274, 176045, 202302, 216062)
- Fondazione AIRC per la ricerca sul cancro ETS (IG 22030)
- ISREC Foundation
- Prostate Cancer Foundation (19CHAL08)
- Novartis Foundation for Medical-Biological Research (21A009)
- Associazione Italiana per la Ricerca sul Cancro
- Portland Community Fund
- Novartis Foundation
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- mitochondrial DNA release, cellular senescence, therapy-induced senescence, polymorphonuclear myeloid-derived suppressor cells, cGAS-STING pathway, NF-κB signaling, PERK signaling, extracellular vesicles, voltage-dependent anion channel, tumor immunosuppression, tumor microenvironment, prostate cancer, chemotherapy efficacy, innate immunity
- MeSH terms
- Myeloid-Derived Suppressor Cells, STING Protein, Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase, Animals, DNA, Mitochondrial, Humans, Immune Tolerance, Male, Membrane Proteins, Mice, Inbred C57BL, Mitochondria, Neutrophils, Nucleotidyltransferases, Prostatic Neoplasms, Signal Transduction, NF-kappa B, Cellular Senescence, Cell Line, Tumor, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review